Anne Tybjærg-Hansen

Anne Tybjærg-Hansen

Clinical Professor

Member of:

  • Clinical Biochemistry


  1. Published

    Report of the 33rd annual conference of the European Lipoprotein Club, Tutzing, 6-9 September 2010

    Bernini, F., Fisher, R., Freeman, D., Groen, A., Kalopissis, A., Malle, E., Mulder, M., Niemeier, A., Parini, P., Tybjærg-Hansen, Anne & von Eckardstein, A., 2011, In: Atherosclerosis. 215, 1, p. 249-55 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Repositioning of the global epicentre of non-optimal cholesterol

    NCD Risk Factor Collaboration (NCD-RisC), N. R. F. C. (., Taddei, C., Zhou, B., Bixby, H., Nordestgaard, Børge, Benn, Marianne, Linneberg, Allan René, Tybjærg-Hansen, Anne, Cisneros, J. Z., Gregg, E. W., Ezzati, M. & Sørensen, Thorkild I.A., 2020, In: Nature. 582, 7810, p. 73-77

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Residual vascular risk in diabetes: Will the SPPARM alpha concept hold the key?

    Fruchart, J. C., Santos, R. D., Yamashita, S., Libby, P., International Atherosclerosis Society/R3i Foundation Consensus Panel, I. A. S. F. C. P., Fruchart, J., Santos, R. D., Yamashita, S., Nordestgaard, Børge, Tybjærg-Hansen, Anne, Watts, G. F., Yokote, K. & Zambon, A., 2019, In: Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 13, 4, p. 2723-2725

    Research output: Contribution to journalReviewResearchpeer-review

  4. Published

    Response to: liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease

    Stender, S. & Tybjærg-Hansen, Anne, 2018, In: European Heart Journal. 39, 36, p. 3399

    Research output: Contribution to journalComment/debateResearchpeer-review

  5. Published

    Response to the Letter: Response to "Use of biomarkers to identify new drug targets and to predict risk of cardiometabolic outcomes" by Abasi A., et al

    Holmegard, H. N., Nordestgaard, Børge, Jensen, G. B., Tybjærg-Hansen, Anne & Benn, Marianne, Feb 2016, In: The Journal of clinical endocrinology and metabolism. 101, 2, p. L22-L23

    Research output: Contribution to journalLetterResearchpeer-review

  6. Published

    Risk of cancer by ATM missense mutations in the general population

    Dombernowsky, S. L., Weischer, M., Allin, K. H., Bojesen, Stig Egil, Tybjærg-Hansen, Anne & Nordestgaard, B. G., 2008, In: Journal of Clinical Oncology. 26, 18, p. 3057-62 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Risk of cancer by transferrin saturation levels and haemochromatosis genotype: population-based study and meta-analysis

    Ellervik, Christina, Tybjærg-Hansen, Anne, Nordestgaard, Børge, Ellervik, Christina, Tybjærg-Hansen, Anne & Nordestgaard, Børge, 2012, In: Journal of Internal Medicine. 271, 1, p. 51-63 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Risk of ischemic heart and ischemic cerebrovascular disease is not increased in S, Z, and 11478A alpha1-antitrypsin carriers of the Copenhagen City Heart Study

    Dahl, M., Tybjærg-Hansen, Anne & Nordestgaard, Børge, 1 Nov 2003, In: Arteriosclerosis, Thrombosis, and Vascular Biology. 23, 11, p. e55; author reply e55

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease

    Argraves, K. M., Sethi, A. A., Gazzolo, P. J., Wilkerson, B. A., Remaley, A. T., Tybjærg-Hansen, Anne, Nordestgaard, Børge, Yeatts, S. D., Nicholas, K. S., Barth, J. L. & Argraves, W. S., 2011, In: Lipids in Health and Disease. 10, p. 70

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe

    Hageman, S., Pennells, L., Ojeda, F., Kaptoge, S., Kuulasmaa, K., de Vries, T., Xu, Z., Kee, F., Chung, R., Wood, A., McEvoy, J. W., Veronesi, G., Bolton, T., Dendale, P., Ference, B. A., Halle, M., Timmis, A., Vardas, P., Danesh, J., Graham, I. & 32 others, Salomaa, V., Visseren, F., De Bacquer, D., Blankenberg, S., Dorresteijn, J., Di Angelantonio, E., Achenbach, S., Aleksandrova, K., Amiano, P., Amouyel, P., Andersson, J., Bakker, S. J. L., Costa, R. B. D. P., Beulens, J. W. J., Blaha, M., Bobak, M., Boer, J. M. A., Bonet, C., Bonnet, F., Boutron-Ruault, M., Braaten, T., Brenner, H., Brunner, F., Brunner, E. J., Brunstrom, M., Jørgensen, T., Linneberg, Allan René, Overvad, K., Tjønneland, Anne, Tybjærg-Hansen, Anne, SCORE2 Working Grp, S. W. G. & ESC Cardiovasc Risk Collaboration, E. C. R. C., 2021, In: European Heart Journal. 42, 25, p. 2439-2454 16 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 924951